City ramps up production of single-dose COVID-19 vaccine
April 08, 2021
China is speeding up production of a single-dose COVID-19 vaccine in Shanghai, with annual production capacity of about 200 million units, Shanghai Daily learned today at the Shanghai Global Investment Promotion Conference.
Shanghai Pharmaceuticals and STAR-listed CanSino Biologics will produce the one-shot vaccines in a factory in Baoshan District, with an investment of 400 million yuan (US$62.5 million).
Total investment in the project, which covers COVID-19 and other vaccines, will reach 1.5 billion yuan.